The global Cell Expansion Market Growth Accelerated by increasing investments in cell-based research
The cell expansion process is used to grow cells in an artificial environment outside the body. It finds widespread application in areas of cell-based research, bioprocessing, biomanufacturing, and regenerative medicine. Increase in prevalence of chronic diseases has accelerated the demand for cell-based therapies & regenerative medicine, driving investments in cell-based research. The global Cell Expansion Market is estimated to be valued at US$ 16,035.5 Mn in 2023 and is expected to exhibit a CAGR of 11% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
The increasing investments by both private and public bodies in cell-based
research is one of the key trends driving the growth of the cell
expansion market. Governments across regions are providing increased
funding for cell-based research activities. For instance, the U.S. government
increased its funding for cell-based research by 11% from 2019 to 2020.
Similarly, the U.K. government invested £123 million in 2021 for regenerative
medicine and cell therapies. Such increased investments are encouraging cell
therapy developers to focus on cell expansion techniques to meet the growing
demand of cell-based applications, thereby driving the market growth over the
forecast period.
There are two major sub-segments in the cell expansion market - consumables and equipment. The consumables sub-segment dominates the market as it needs to be replaced periodically. Cell culture media, reagents, and sera are the major consumables used for cell expansion processes. The need for repeated purchasing of these consumables to culture cells contributes to the large market share of this sub-segment.
Key Takeaways
The global cell expansion market is expected to witness high growth. Advancements in cell-based therapies and growing stem cell research are driving the demand for cell expansion solutions. The increasing incidence of chronic and infectious diseases is also boosting the market.
Regional analysis
North America dominates the global cell expansion market currently due to heavy investments in stem cell and immunology research in the region. The strong presence of key players and growing biotechnology industry also support market growth in North America. Asia Pacific is expected to witness the fastest growth over the forecast period. This can be attributed to increasing government support for stem cell research, rising healthcare expenditure, and growing biopharmaceutical industry in China, India, and Japan.
Key players
Key players operating in the cell expansion market are Becton, Dickinson and Company, Sartorius AG, Merck KGaA, Corning, Inc., Eppendorf SE, Lonza Group AG, PromoCell, Danaher, Thermo Fisher Scientific, HiMedia Laboratories, STEMCELL Technologies Inc., REPROCELL Inc., Bio-Techne, Valiant Co., Ltd., Miltenyi Biotec, Biologos, Cyagen US Inc. Becton, Dickinson and Company and Thermo Fisher Scientific are the market leaders due to their robust product portfolio and global presence.

Comments
Post a Comment